lucida ds glutathione C + (@LucidaVitC) • Facebook Humanization of autoantigen | Nature

doi: 10.3389/fmolb.2021.649395, Summary Keywords bloodbrain barrier, brain targeting, nanocarriers, nano-phytomedicine, neurodegeneration, phytochemicals Citation Naim A, Farooqui AM, Badruddeen, Khan MI, Akhtar J, Ahmad A, Ashique S and Islam A (2026) Nanoengineered phytochemicals overcome bloodbrain barrier constraints in neurodegenerative disorders

This offers new insights into combination strategies involving targeted drugs (such as anti-EGFR or BCL-2 inhibitors) with cuproptosis inducers, which are particularly applicable to drug-resistant tumors with hyperactive mitochondrial metabolism, though further clinical validation is required

Most therapeutic interventions remain in preclinical development, with clinical translation hindered by two key barriers: The lack of validated biomarkers for patient stratification and incomplete elucidation of synergistic combination mechanisms

Objectives The aim of the current study was to identify metabolites and metabolic pathways associated with circulating pro-inflammatory cytokines under homeostatic conditions using a metabolomics approach

Proteostasis in Parkinsons disease: recent development and possible implication in diagnosis and therapeutics